Keyphrases
Malaria
87%
Cerebral Malaria
83%
Plasmodium Falciparum
78%
Uncomplicated Malaria
52%
Artemether-lumefantrine
47%
Falciparum Malaria
40%
Artesunate-mefloquine
38%
Ghanaian children
33%
Malaria Model
32%
Population Pharmacokinetics
31%
Erythropoietin
30%
Amodiaquine
27%
Plasmodium Berghei
25%
Erythropoietin Therapy
23%
Antimalarial Drugs
23%
Non-associated
22%
Antibiotics
22%
Experimental Cerebral Malaria
22%
Ghana
20%
Point Prevalence Survey
20%
Vascular Endothelial Growth Factor
20%
AIDS/HIV
20%
Sickle Cell Disease
20%
Pneumocystis Jirovecii
20%
Desethylamodiaquine
20%
Interleukin-10
20%
Infected Erythrocytes
19%
Neonate
19%
Artemisinin-based Combination Therapy
18%
Ghanaians
18%
Polymorphism
17%
Plasmodium Berghei ANKA
17%
Antibiotic Use
16%
Malaria Infection
16%
Parasitemia
15%
Therapy Regimen
15%
Glycocalyx
15%
Diphtheria-tetanus-pertussis
15%
Infections in children
15%
Korle-Bu Teaching Hospital
15%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebral Malaria
60%
Amodiaquine
52%
Artemether Plus Benflumetol
45%
Infection
37%
Artesunate
37%
Antimalarial Agent
31%
Prevalence
28%
Diseases
27%
Anemia
21%
Pharmacokinetic
20%
Sickle Cell Anemia
20%
Retinol
20%
Iron
20%
Bloodstream Infection
20%
Deethylamodiaquine
18%
Malaria Falciparum
17%
HIV
15%
Antibiotics
15%
Diphtheria
15%
Tetanus
15%
Immunology and Microbiology
Plasmodium falciparum
100%
Plasmodium berghei
49%
Erythrocyte
35%
Prevalence
32%
Glycocalyx
31%
Human immunodeficiency virus
27%
Blood Plasma
21%
Artemether
20%
Pneumocystis jiroveci
20%
Interleukin 10
17%
C-Reactive Protein
17%
Cryptosporidium
16%
Parasitemia
16%
Chinese hamster
16%
Entamoeba histolytica
15%
Ovary Cell
15%